VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma
- PMID: 21097568
- DOI: 10.1530/EJE-10-0967
VEGFR1 expression is related to lymph node metastasis and serum VEGF may be a marker of progression in the follow-up of patients with differentiated thyroid carcinoma
Abstract
Objective: Vascular endothelial growth factor (VEGF) and VEGF receptor 1 (VEGFR1) are known to be related to thyroid tumorigenesis. The aim of the study was to examine the expressions and serum levels of VEGF, VEGFR1, IGF1, and IGF1 receptor (IGF1R) in patients with differentiated thyroid carcinoma (DTC) compared with patients with nodular goiter (NG).
Methods: We examined 39 patients with DTC who had a clinical history of at least 2 years and compared them with 25 patients who had a pathological diagnosis of NG after thyroidectomy. Serum VEGF, VEGFR1, and IGF1 levels were measured in both patient groups. The expressions of VEGF, VEGFR1, IGF1, and IGF1R were analyzed by the immunohistochemical method in the paraffin blocks of patients' thyroidectomy samples of the patients.
Results: The immunostainings scores for VEGF, VEGFR1, IGF1, and IGF1R were found to be higher in patients with DTC than in those with NG. Only VEGFR1 expression was related to lymph node metastasis at the time of surgery. None of the expressions were related to the long-term prognosis of the patients. Serum VEGF was found to be higher in patients with progressive DTC than in patients in clinical remission.
Conclusion: The expressions of VEGF and VEGFR1 were shown to be correlated with the expression of IGF1 and IGF1R. VEGFR1 expression may be an important index for the presence of lymph node metastasis at the time of thyroidectomy. Increased serum levels of VEGF may reflect disease recurrence in DTC.
Similar articles
-
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.Clin Cancer Res. 2005 Nov 15;11(22):8063-9. doi: 10.1158/1078-0432.CCR-05-0646. Clin Cancer Res. 2005. PMID: 16299237
-
[Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].Ai Zheng. 2005 Sep;24(9):1136-9. Ai Zheng. 2005. PMID: 16159441 Chinese.
-
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.Ann Surg. 2008 Mar;247(3):483-9. doi: 10.1097/SLA.0b013e31815fa447. Ann Surg. 2008. PMID: 18376194
-
Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.Clin Nucl Med. 2012 Mar;37(3):e40-6. doi: 10.1097/RLU.0b013e31823905e4. Clin Nucl Med. 2012. PMID: 22310269
-
Surgical management of cervical lymph nodes in differentiated thyroid cancer.Otolaryngol Clin North Am. 2010 Apr;43(2):285-300, viii. doi: 10.1016/j.otc.2010.01.005. Otolaryngol Clin North Am. 2010. PMID: 20510715 Review.
Cited by
-
Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma.Tumour Biol. 2014 Sep;35(9):9045-51. doi: 10.1007/s13277-014-2124-5. Epub 2014 Jun 9. Tumour Biol. 2014. PMID: 24908415
-
Expression of signal transducer and activator of transcription 3 and its phosphorylated form is significantly upregulated in patients with papillary thyroid cancer.Exp Ther Med. 2015 Jun;9(6):2195-2201. doi: 10.3892/etm.2015.2409. Epub 2015 Apr 7. Exp Ther Med. 2015. PMID: 26136959 Free PMC article.
-
Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.Int J Clin Exp Pathol. 2014 Dec 1;7(12):8506-19. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674215 Free PMC article.
-
Dexamethasone Inhibits Spheroid Formation of Thyroid Cancer Cells Exposed to Simulated Microgravity.Cells. 2020 Feb 5;9(2):367. doi: 10.3390/cells9020367. Cells. 2020. PMID: 32033410 Free PMC article.
-
IGF Bioregulation System in Benign and Malignant Thyroid Nodular Disease: A Systematic Review.In Vivo. 2020 Nov-Dec;34(6):3069-3091. doi: 10.21873/invivo.12141. In Vivo. 2020. PMID: 33144411 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous